Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study.
about
Peritoneal Dialysis in Western CountriesEffect of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and Ultrafiltration: A Systematic Review and Meta-AnalysisManagement of patients with a failed kidney transplant: Dialysis reinitiation, immunosuppression weaning, and transplantectomyThe Association between Nutritional Markers and Biochemical Parameters and Residual Renal Function in Peritoneal Dialysis PatientsThe Current State of Peritoneal DialysisPreservation of residual kidney function in hemodialysis patients: reviving an old concept.Association of Alternative Approaches to Normalizing Peritoneal Dialysis Clearance with Mortality and Technique Failure: A Retrospective Analysis Using the United States Renal Data System-Dialysis Morbidity and Mortality Study, Wave 2.End stage renal disease.Rationale and design of BISTRO: a randomized controlled trial to determine whether bioimpedance spectroscopy-guided fluid management maintains residual kidney function in incident haemodialysis patients.Rationale and design of the balANZ trial: a randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal functionRenin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort studyEducating end-stage renal disease patients on dialysis modality selection.End-stage renal diseaseFluid overload as a major target in management of cardiorenal syndrome: Implications for the practice of peritoneal dialysis.Ferritin as a predictor of decline in residual renal function in peritoneal dialysis patients.Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy.Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes.High peritoneal transport status is not an independent risk factor for high mortality in patients treated with automated peritoneal dialysisBenefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients.Is hypoalbuminemia a prognostic risk factor for contrast-induced nephropathy in peritoneal dialysis patients?The impact of an "acute dialysis start" on the mortality attributed to the use of central venous catheters: a retrospective cohort study.Risk factors associated with brachial-ankle pulse wave velocity among peritoneal dialysis patients in Macao.Impact of heavy proteinuria on clinical outcomes in patients on incident peritoneal dialysisControl of fluid balance guided by body composition monitoring in patients on peritoneal dialysis (COMPASS): study protocol for a randomized controlled trialPrevalence and risk factors of fluid overload in Southern Chinese continuous ambulatory peritoneal dialysis patients.Prognostic factors of all-cause mortalities in continuous ambulatory peritoneal dialysis: a cohort study.Laparoscopic versus open peritoneal dialysis catheter insertion: a meta-analysisRole of residual renal function in phosphate control and anemia management in chronic hemodialysis patientsContribution of residual function to removal of protein-bound solutes in hemodialysisEffect of biocompatible peritoneal dialysis solution on residual renal function: a systematic review of randomized controlled trials.Assessing creatinine clearance from modification of diet in renal disease study equations in the ADEMEX cohort: limitations and potential applications.Estimated glomerular filtration rate -a more stable indicator than creatinine clearance in peritoneal dialysis practiceHigh-sensitivity C-reactive protein predicts mortality and technique failure in peritoneal dialysis patients.Selection bias explains apparent differential mortality between dialysis modalities.Functional genomic analysis identifies indoxyl sulfate as a major, poorly dialyzable uremic toxin in end-stage renal disease.Utility of Urinary Biomarkers in Predicting Loss of Residual Renal Function: The balANZ TrialComparison of the impact of "fast decline" in residual renal function and "initial anuria" on long-term outcomes in CAPD patients.Risk factors for mortality in Chinese patients on continuous ambulatory peritoneal dialysisPreserving residual renal function in dialysis patients: an update on evidence to assist clinical decision making.
P2860
Q26740468-94994E86-37D4-41B1-AF3D-99711C15DD88Q26852444-500A482B-3228-4DB9-B31C-5ECF15296926Q27693912-231A4CC4-3C9F-4FC8-895F-44A6F627B4EFQ28552675-BFB75C86-ECA5-40D1-AC33-435DB7EAFF47Q30243902-30C10778-CFD3-49C8-8BE9-0F64C07B31F5Q30250300-87BD5492-5942-4787-B1E1-D67ABE1467D0Q31133575-F1554892-C066-421B-B38C-FF0ACF753A95Q33446829-8230729C-17E9-4ACD-B4A9-52BDEF5B426AQ33604310-B2D26D72-54BB-4A3B-A899-321F822616CDQ33693392-C7E2D38D-6E4D-4CE4-9FF4-9E579AE872B5Q33808339-3B8BB774-1C19-456F-B21F-9449356C3607Q33816963-CE25086E-44B0-4932-89E4-19EC94F889F1Q33850437-5CD49AF3-42C2-4C2A-9229-A0B1ABD8ACBDQ33880939-D293BE57-EA82-4E27-A913-F140FC9F96DCQ33912907-E23CDE2B-F1EC-4CAB-BFB7-64B7559A9B67Q33954138-5484197A-9655-44DC-A5F5-B8CC40901D4BQ34023357-C5AF1760-CCE7-4BF6-BD3E-2F44D66398F6Q34064438-0738C73D-805C-48B3-8735-57A887B6B963Q34073662-EF071613-2C92-4236-B33C-5EEDA6EC179CQ34208270-B94A3C91-9C20-4653-B803-A51745D193FEQ34351241-AFA7CFEF-D1CA-4575-A68F-9518AC7357D9Q34356681-97BCD302-F1B2-4EE0-86CB-AA35BD7D4F80Q34462607-BE54795D-4B3F-448F-ADA3-A7D742213B90Q34514317-A212D591-0BAF-4A1B-9D5C-91DA3B330DF6Q34517768-CCE48227-BDB0-429A-921E-A757052654F5Q34558438-2D414102-BAFC-4D45-94B4-E807EE1D5E95Q34569840-F5734400-BAA1-4DE7-8CD7-DFD77FA8C634Q34606739-28BA6FF5-3E56-4EE5-9828-366DBC32F604Q34639575-F565AF88-7AE4-48F5-9DD4-41D13DBBF5CFQ34639584-B758AAEB-03C2-4DEE-A817-64CECC111971Q34725102-7C49ACA0-1C1F-4650-85E5-FFCBDFA5B1C6Q34857918-B863E165-3E2E-43F8-B835-5E93C2CA6D78Q35022742-0F4A249A-B847-4237-A37E-802DCEE25DE7Q35131398-25365D64-F281-4841-A7C7-6EB2F7AAB472Q35142738-E4CB48EA-84BA-497E-A0AD-F0F5D5782350Q35219453-84DE6B1C-D0B1-4F8C-8990-A69905C538F6Q35524711-79213959-9A66-454F-87EE-59664197819AQ35524725-F1A88729-176B-48A9-8473-264F1B14E9F6Q35524771-DE7BBCC1-848F-4D80-9F1D-1FBBDF309496Q35574112-D245AB3D-7882-412D-A447-21062228E547
P2860
Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Relative contribution of resid ...... eanalysis of the CANUSA study.
@en
Relative contribution of resid ...... eanalysis of the CANUSA study.
@nl
type
label
Relative contribution of resid ...... eanalysis of the CANUSA study.
@en
Relative contribution of resid ...... eanalysis of the CANUSA study.
@nl
prefLabel
Relative contribution of resid ...... eanalysis of the CANUSA study.
@en
Relative contribution of resid ...... eanalysis of the CANUSA study.
@nl
P2093
P1476
Relative contribution of resid ...... reanalysis of the CANUSA study
@en
P2093
CANUSA Peritoneal Dialysis Study Group
D N Churchill
J M Bargman
P304
P577
2001-10-01T00:00:00Z